These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3928233)

  • 41. [Distribution of gold from aurothiomalate and gold trielthylphosphine in whole blood, lymphocytes and lymphocyte chromatin of patients with chronic polyarthritis].
    Teherani DK; Altmann H; Tausch G; Eberl R
    Wien Klin Wochenschr Suppl; 1984; 156():53-5. PubMed ID: 6442060
    [No Abstract]   [Full Text] [Related]  

  • 42. Current status of disease-modifying drugs in progressive rheumatoid arthritis.
    O'Duffy JD; Luthra HS
    Drugs; 1984 May; 27(5):373-7. PubMed ID: 6426922
    [No Abstract]   [Full Text] [Related]  

  • 43. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
    Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
    J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Other penicillamine-like drugs.
    Huskisson EC
    J Rheumatol Suppl; 1981; 7():180-1. PubMed ID: 6785437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Roentgenographic findings during auranofin treatment.
    Gofton JP; O'Brien W
    Am J Med; 1983 Dec; 75(6A):142-4. PubMed ID: 6419597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Auranofin: 1 mg or 9 mg? The search for the appropriate dose.
    Calin A; Saunders D; Bennett R; Jacox R; Kaplan D; O'Brien W; Paulus HE; Roth S; Weiss T
    J Rheumatol Suppl; 1982; 8():146-8. PubMed ID: 6813476
    [No Abstract]   [Full Text] [Related]  

  • 47. Oral chrysotherapy in rheumatoid arthritis: minimum effective dose.
    Finkelstein AE; Roisman FR; Batista V; de Nudelman FG; de Titto EH; Mizraji M; Walz DT
    J Rheumatol; 1980; 7(2):160-8. PubMed ID: 6768887
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis.
    Katz WA; Alexander S; Bland JH; Blechman W; Bluhm GB; Bonebrake RA; Falbo A; Greenwald RA; Hartman S; Hobbs T; Indenbaum S; Lergier JE; Lanier BG; Lightfoot RW; Phelps P; Sheon RP; Torretti D; Wenger ME; Wilske K
    J Rheumatol Suppl; 1982; 8():173-8. PubMed ID: 6813481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single dose pharmacokinetics of auranofin in rheumatoid arthritis.
    Blocka K; Furst DE; Landaw E; Dromgoole S; Blomberg A; Paulus HE
    J Rheumatol Suppl; 1982; 8():110-9. PubMed ID: 6813473
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blood and serum concentrations of gold after a single dose of auranofin in children with juvenile rheumatoid arthritis.
    Giannini EH; Person DA; Brewer EJ; Parks DB
    J Rheumatol; 1983 Jun; 10(3):496-8. PubMed ID: 6411921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral gold (auranofin) in juvenile rheumatoid arthritis: a 48-week phase II study.
    Kvien TK; Høyeraal HM; Sandstad B; Kåss E
    Clin Rheumatol; 1984 Dec; 3(4):551-2. PubMed ID: 6441669
    [No Abstract]   [Full Text] [Related]  

  • 52. Investigation of auranofin-induced diarrhoea.
    Behrens R; Devereaux M; Hazleman B; Szaz K; Calvin J; Neale G
    Gut; 1986 Jan; 27(1):59-65. PubMed ID: 3081411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rheumatoid arthritis.
    Hughes GR
    Br J Hosp Med; 1979 Jun; 21(6):584-8, 592. PubMed ID: 476332
    [No Abstract]   [Full Text] [Related]  

  • 54. Gold compounds in rheumatic diseases--1.
    Champion GD
    Med J Aust; 1984 Jan; 140(2):73-7. PubMed ID: 6420652
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disease modifying drugs in rheumatoid arthritis--what do they actually do?
    Joshi VR; Sainani GS
    J Assoc Physicians India; 1986 Nov; 34(11):765-6. PubMed ID: 3558296
    [No Abstract]   [Full Text] [Related]  

  • 56. [Development and clinical use of chemical immunomodulators].
    Abe T
    Nihon Rinsho; 1981 Apr; 39(4):1893-901. PubMed ID: 6796722
    [No Abstract]   [Full Text] [Related]  

  • 57. [Does a valid treatment for rheumatoid arthritis exist?].
    Lience E
    Med Clin (Barc); 1986 Apr; 86(14):587-9. PubMed ID: 3724266
    [No Abstract]   [Full Text] [Related]  

  • 58. Slow acting drugs--outcome no different than 15 years ago.
    Ferraccioli G; Salaffi F; Nervetti A; Cavalieri F
    J Rheumatol; 1990 Sep; 17(9):1249-50. PubMed ID: 2290173
    [No Abstract]   [Full Text] [Related]  

  • 59. Gold therapy. II. Historical, chemical, pharmacological and biological profile of anti-arthritic gold compounds.
    Kean WF; Gerecz E; Hogan MG
    Singapore Med J; 1987 Apr; 28(2):117-25. PubMed ID: 3155422
    [No Abstract]   [Full Text] [Related]  

  • 60. Gold in rheumatoid arthritis therapy today. Early treatment.
    Luukkainen R
    Scand J Rheumatol Suppl; 1983; 51():118-9. PubMed ID: 6372080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.